|
|
Time Trends in Incidence of Motor Neuron Diseases in France: A Comprehensive 14‐Year Nationwide Study (2010–2023)
Octave Guinebretiere
,
Quentin Calonge
,
Gaëlle Bruneteau
,
Maria‐del‐mar Amador
,
Thomas Nedelec
Article dans une revue
hal-05039352
v1
|
|
|
Incidence, mortality, and management of status epilepticus from 2012 to 2022: An 11‐year nationwide study
Quentin Calonge
,
Aurélie Hanin
,
Edouard Januel
,
Octave Guinebretiere
,
Thomas Nedelec
et al.
Article dans une revue
hal-05276617
v1
|
|
|
Updated Multiple Sclerosis Incidence in France, 2011–2021
Octave Guinebretiere
,
Chloé Pierret
,
Quentin Calonge
,
Edouard Januel
,
Celine Louapre
et al.
Article dans une revue
hal-05034515
v1
|
|
|
How Reliable Is the G41 Discharge Code for Status Epilepticus?
Quentin Calonge
,
Vincent Navarro
,
Sophie Tezenas Du Montcel
Article dans une revue
hal-05034632
v1
|
|
|
Recurrence and Mortality After a First Status Epilepticus
Quentin Calonge
,
Octave Guinebretiere
,
Thomas Nedelec
,
Aurélie Hanin
,
Francois Le Gac
et al.
Article dans une revue
hal-05281729
v1
|
|
|
Comparing three natural language processing methods for the automatic identification of epilepsy patients from French clinical notes
François Le Gac
,
Quentin Calonge
,
Candice Estellat
,
Vincent Navarro
Article dans une revue
hal-05335149
v1
|
|
|
Burden of Status Epilepticus: prognosis and cost driving factors, insight from a nationwide retrospective cohort study of the French health insurance database
Quentin Calonge
,
François Le Gac
,
Mario Chavez
,
Adeline Degremont
,
Catherine Quantin
et al.
Article dans une revue
hal-04701239
v1
|
|
|
Cannabidiol Treatment for Adult Patients with Drug‐Resistant Epilepsies: A Real‐World Study in a Tertiary Center
Quentin Calonge
,
Aurore Besnard
,
Laurent Bailly
,
Maria Damiano
,
Phintip Pichit
et al.
Article dans une revue
hal-04779920
v1
|